Evolving Guidelines in Pericarditis: Aligning Practice With Pathophysiology [0.03%]
心包炎的诊疗指南在变迁：病理生理与临床实践的和谐统一
Muhammad Ehsan,Jibran Ikram,Joseph El Roumi et al.
Muhammad Ehsan et al.
Current Practice and Safety of Invasive Coronary Function Testing: A Nationwide Multicenter Survey in Japan [0.03%]
日本全国多中心冠状动脉功能检测的现状和安全性调查研究
Takeshi Nishi,Michikazu Nakai,Masanobu Ishii et al.
Takeshi Nishi et al.
Background: Coronary vasomotor dysfunction-including vasospastic angina and coronary microvascular dysfunction-is a key mechanism underlying ischemia or myocardial infarction with nonobstructive coronary arteries (INOCA/M...
Shaun Khanna,Nitesh Nerlekar,Aditya Bhat
Shaun Khanna
Analysis of Closed Claims in Cardiovascular Medicine: Importance of Nonclinical Factors [0.03%]
心血管医学中闭案分析：非临床因素的重要性分析
Fred Kusumoto,David M Dudzinski,Jacqueline Ross et al.
Fred Kusumoto et al.
Background: Medical professional liability claims are a marker of conflict between a patient and a health care provider. Objectives: Th...
A Deep Learning Model to Guide Personalized Mechanical Circulatory Support Use in Cardiogenic Shock Patients Undergoing PCI [0.03%]
一种用于指导经皮冠状动脉介入治疗的急性心源性休克患者个性化机械循环辅助使用的深度学习模型
Amit P Amin,Richard G Bach,Darren C Tsang et al.
Amit P Amin et al.
Background: Cardiogenic shock (CS) in patients undergoing percutaneous coronary intervention (PCI) involves rapidly changing clinical, hemodynamic, and metabolic factors that current models cannot effectively integrate. ...
Metabolic Signatures of Air Pollution and Major Adverse Cardiovascular Events in Patients Undergoing Cardiac Catheterization [0.03%]
冠状动脉造影患者的代谢标志物与空气污染和主要不良心血管事件之间的关系
Chang Liu,Duan Wang,Zhihao Jin et al.
Chang Liu et al.
Background: Air pollution is an environmental risk factor for coronary artery disease. The molecular mechanisms linking fine particulate matter (PM2.5), nitrogen oxide (NOx), and carbon monoxide (CO) to coronary artery di...
Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled [0.03%]
恩格列净与心力衰竭和既往冠状动脉重建术的关联：来自EMPEROR合并研究的洞见
Nitish K Dhingra,Javed Butler,Stefan D Anker et al.
Nitish K Dhingra et al.
Background: Sodium glucose co-transporter-2 inhibitors are a foundational therapy for the management of chronic heart failure (HF). Objectives: ...
Association of Objective Physical Activity and Mortality in American Heart Association's Life's Essential 8 [0.03%]
美国心脏协会“生命八大必需”中客观体力活动与死亡率的关系
Anthony Mufarreh,Kushagra Vashist,Jacob Germany et al.
Anthony Mufarreh et al.
Background: The American Heart Association's (AHA) Life's Essential 8 (LE8) highlights key factors for cardiovascular health, including physical activity (PA). However, existing research relies on self-reported PA data, w...
Bicuspid Aortic Valve Leaflet Modification Before Transcatheter Aortic Valve Replacement: A New Paradigm [0.03%]
经导管主动脉瓣置换前的二叶式主动脉瓣瓣叶改良：一种新方法论
Hasan Jilaihawi,Martin B Leon,Roy D Dar et al.
Hasan Jilaihawi et al.
Background: Transcatheter aortic valve replacement (TAVR) deployment in bicuspid aortic valve (BAV) can result in deformed transcatheter heart valves (THVs) due to incomplete, irregular, and eccentric stent expansion. Adj...
Patient-Led Smartwatch ECG Follow-Up Strategy After AF Ablation: Clinical Trial Design and Implementation [0.03%]
一项关于患者主导的智能手表心电图技术在射频消融术后随访中的作用的临床试验的设计与实施
Nikhil Ahluwalia,Hakam Abbass,Ahmed Hussain et al.
Nikhil Ahluwalia et al.
Background: Conventional follow-up after atrial fibrillation (AF) catheter ablation relies on physician-led interval monitoring and often fails to characterize paroxysmal symptoms. An increasing number of patients use sma...